More for less: predicting and maximizing genomic variant discovery via Bayesian nonparametrics

<jats:title>Summary</jats:title> <jats:p>While the cost of sequencing genomes has decreased dramatically in recent years, this expense often remains nontrivial. Under a fixed budget, scientists face a natural trade-off between quantity and quality: spending resources to sequence a...

Full description

Bibliographic Details
Main Authors: Masoero, Lorenzo (Author), Camerlenghi, Federico (Author), Favaro, Stefano (Author), Broderick, Tamara (Author)
Format: Article
Language:English
Published: Oxford University Press (OUP), 2022-06-07T12:26:26Z.
Subjects:
Online Access:Get fulltext
LEADER 01833 am a22001933u 4500
001 142893
042 |a dc 
100 1 0 |a Masoero, Lorenzo  |e author 
700 1 0 |a Camerlenghi, Federico  |e author 
700 1 0 |a Favaro, Stefano  |e author 
700 1 0 |a Broderick, Tamara  |e author 
245 0 0 |a More for less: predicting and maximizing genomic variant discovery via Bayesian nonparametrics 
260 |b Oxford University Press (OUP),   |c 2022-06-07T12:26:26Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/142893 
520 |a <jats:title>Summary</jats:title> <jats:p>While the cost of sequencing genomes has decreased dramatically in recent years, this expense often remains nontrivial. Under a fixed budget, scientists face a natural trade-off between quantity and quality: spending resources to sequence a greater number of genomes or spending resources to sequence genomes with increased accuracy. Our goal is to find the optimal allocation of resources between quantity and quality. Optimizing resource allocation promises to reveal as many new variations in the genome as possible. We introduce a Bayesian nonparametric methodology to predict the number of new variants in a follow-up study based on a pilot study. When experimental conditions are kept constant between the pilot and follow-up, we find that our prediction is competitive with the best existing methods. Unlike current methods, though, our new method allows practitioners to change experimental conditions between the pilot and the follow-up. We demonstrate how this distinction allows our method to be used for more realistic predictions and for optimal allocation of a fixed budget between quality and quantity. We validate our method on cancer and human genomics data.</jats:p> 
546 |a en 
655 7 |a Article 
773 |t 10.1093/BIOMET/ASAB012 
773 |t Biometrika